Chiesi USA, Inc. recalls Revcovi (elapegademase-lvlr) Injection, 2.4mg/1.5mL (1.6 mg/mL), Single-Dose Vial, Rx Only, For Intramuscular Use Only, Mfd. by Chiesi…
Failed Stability Specifications: Out of specification stability result for the protein concentration profile.
Read the official notice →- Date
- 2026-09-09
- Country
- United States
- Brand
- Chiesi
- Product
- Revcovi (elapegademase-lvlr) Injection, 2.4mg/1.5mL (1.6 mg/mL), Single-Dose Vial, Rx Only, For Intramuscular Use Only, Mfd. by Chiesi…
- Classification
- Class III
- Units
- MO, TN
- Category
- Drugs & medical
- Source
- FDA · Drug
Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer
What to do
- Check the product name, strength and lot number against the official notice.
- Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
- Ask the pharmacy or supplier about a replacement or refund.
General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.
More Chiesi recalls
- 2026-07-22
US- 2026-04-01
- US
Other drugs & medical recalls in the United States
- 2026-09-09
- US
Golden State Medical Supply Inc. recalls Prasugrel HCI, Tablets, USP, 10mg, 30-count bottle, Rx only, Marketed by: GSMS, Incorporated, Camarillo, CA 93012, USA, NDC:…
Failed Dissolution Specifications. Notification from the manufacturer that lot is being recalled due to failed dissolution
- US
- US
Mylan Pharmaceuticals Inc recalls Prasugrel Tablets, USP, 10mg, Rx only, 30 Tablets in each bottle, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505,…
Failed Dissolution Specifications; product failed to meet 18-month stability testing acceptance criteria
- US
- US
- US